Global Neurological Disorder Drugs Industry Market Research Report
The Neurological Disorder Drugs market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Neurological Disorder Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Neurological Disorder Drugs market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Neurological Disorder Drugs market.
The Neurological Disorder Drugs market can be split based on product types, major applications, and important regions.
Major Players in Neurological Disorder Drugs market are:
Bayer AG
Merck & Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca
Teva Pharmaceutical Industries Ltd.
Novartis AG
Major Regions play vital role in Neurological Disorder Drugs market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Neurological Disorder Drugs products covered in this report are:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
Most widely used downstream fields of Neurological Disorder Drugs market covered in this report are:
Hospital
Clinic
Home
There are 13 Chapters to thoroughly display the Neurological Disorder Drugs market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.
Chapter 1: Neurological Disorder Drugs Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Neurological Disorder Drugs Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Neurological Disorder Drugs.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Neurological Disorder Drugs.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Neurological Disorder Drugs by Regions (2013-2018).
Chapter 6: Neurological Disorder Drugs Production, Consumption, Export and Import by Regions (2013-2018).
Chapter 7: Neurological Disorder Drugs Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Neurological Disorder Drugs.
Chapter 9: Neurological Disorder Drugs Market Analysis and Forecast by Type and Application (2018-2023).
Chapter 10: Market Analysis and Forecast by Regions (2018-2023).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.
The Neurological Disorder Drugs market can be split based on product types, major applications, and important regions.
Major Players in Neurological Disorder Drugs market are:
Bayer AG
Merck & Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca
Teva Pharmaceutical Industries Ltd.
Novartis AG
Major Regions play vital role in Neurological Disorder Drugs market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Neurological Disorder Drugs products covered in this report are:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
Most widely used downstream fields of Neurological Disorder Drugs market covered in this report are:
Hospital
Clinic
Home
There are 13 Chapters to thoroughly display the Neurological Disorder Drugs market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.
Chapter 1: Neurological Disorder Drugs Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Neurological Disorder Drugs Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Neurological Disorder Drugs.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Neurological Disorder Drugs.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Neurological Disorder Drugs by Regions (2013-2018).
Chapter 6: Neurological Disorder Drugs Production, Consumption, Export and Import by Regions (2013-2018).
Chapter 7: Neurological Disorder Drugs Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Neurological Disorder Drugs.
Chapter 9: Neurological Disorder Drugs Market Analysis and Forecast by Type and Application (2018-2023).
Chapter 10: Market Analysis and Forecast by Regions (2018-2023).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.
Global Neurological Disorder Drugs Industry Market Research Report
1 NEUROLOGICAL DISORDER DRUGS INTRODUCTION AND MARKET OVERVIEW
1.1 Objectives of the Study
1.2 Definition of Neurological Disorder Drugs
1.3 Neurological Disorder Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Neurological Disorder Drugs Value ($) and Growth Rate from 2013-2023
1.4 Market Segmentation
1.4.1 Types of Neurological Disorder Drugs
1.4.2 Applications of Neurological Disorder Drugs
1.4.3 Research Regions
1.4.3.1 North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.2 Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.3 China Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.4 Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.5 Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.6 India Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.7 South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Neurological Disorder Drugs
1.5.1.2 Growing Market of Neurological Disorder Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 INDUSTRY CHAIN ANALYSIS
2.1 Upstream Raw Material Suppliers of Neurological Disorder Drugs Analysis
2.2 Major Players of Neurological Disorder Drugs
2.2.1 Major Players Manufacturing Base and Market Share of Neurological Disorder Drugs in 2017
2.2.2 Major Players Product Types in 2017
2.3 Neurological Disorder Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Neurological Disorder Drugs
2.3.3 Raw Material Cost of Neurological Disorder Drugs
2.3.4 Labor Cost of Neurological Disorder Drugs
2.4 Market Channel Analysis of Neurological Disorder Drugs
2.5 Major Downstream Buyers of Neurological Disorder Drugs Analysis
3 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET, BY TYPE
3.1 Global Neurological Disorder Drugs Value ($) and Market Share by Type (2013-2018)
3.2 Global Neurological Disorder Drugs Production and Market Share by Type (2013-2018)
3.3 Global Neurological Disorder Drugs Value ($) and Growth Rate by Type (2013-2018)
3.4 Global Neurological Disorder Drugs Price Analysis by Type (2013-2018)
4 NEUROLOGICAL DISORDER DRUGS MARKET, BY APPLICATION
4.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2013-2018)
4.2 Downstream Buyers by Application
4.3 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2013-2018)
5 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, VALUE ($) BY REGION (2013-2018)
5.1 Global Neurological Disorder Drugs Value ($) and Market Share by Region (2013-2018)
5.2 Global Neurological Disorder Drugs Production and Market Share by Region (2013-2018)
5.3 Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.4 North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.5 Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.6 China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.7 Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.8 Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.9 India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.10 South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
6 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2013-2018)
6.1 Global Neurological Disorder Drugs Consumption by Regions (2013-2018)
6.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.4 China Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.6 Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.7 India Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.8 South America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
7 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET STATUS AND SWOT ANALYSIS BY REGIONS
7.1 North America Neurological Disorder Drugs Market Status and SWOT Analysis
7.2 Europe Neurological Disorder Drugs Market Status and SWOT Analysis
7.3 China Neurological Disorder Drugs Market Status and SWOT Analysis
7.4 Japan Neurological Disorder Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Neurological Disorder Drugs Market Status and SWOT Analysis
7.6 India Neurological Disorder Drugs Market Status and SWOT Analysis
7.7 South America Neurological Disorder Drugs Market Status and SWOT Analysis
8 COMPETITIVE LANDSCAPE
8.1 Competitive Profile
8.2 Bayer AG
8.2.1 Company Profiles
8.2.2 Neurological Disorder Drugs Product Introduction
8.2.3 Bayer AG Production, Value ($), Price, Gross Margin 2013-2018E
8.2.4 Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.3 Merck & Co.
8.3.1 Company Profiles
8.3.2 Neurological Disorder Drugs Product Introduction
8.3.3 Merck & Co. Production, Value ($), Price, Gross Margin 2013-2018E
8.3.4 Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Profiles
8.4.2 Neurological Disorder Drugs Product Introduction
8.4.3 F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
8.4.4 F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.5 GlaxoSmithKline plc
8.5.1 Company Profiles
8.5.2 Neurological Disorder Drugs Product Introduction
8.5.3 GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2013-2018E
8.5.4 GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.6 Boehringer Ingelheim GmbH
8.6.1 Company Profiles
8.6.2 Neurological Disorder Drugs Product Introduction
8.6.3 Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2013-2018E
8.6.4 Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.7 AstraZeneca
8.7.1 Company Profiles
8.7.2 Neurological Disorder Drugs Product Introduction
8.7.3 AstraZeneca Production, Value ($), Price, Gross Margin 2013-2018E
8.7.4 AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.8 Teva Pharmaceutical Industries Ltd.
8.8.1 Company Profiles
8.8.2 Neurological Disorder Drugs Product Introduction
8.8.3 Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
8.8.4 Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.9 Novartis AG
8.9.1 Company Profiles
8.9.2 Neurological Disorder Drugs Product Introduction
8.9.3 Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E
8.9.4 Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
9 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION
9.1 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Type (2018-2023)
9.1.1 Antipsychotic Market Value ($) and Volume Forecast (2018-2023)
9.1.2 Hypnotic & Sedative Market Value ($) and Volume Forecast (2018-2023)
9.1.3 Analgesics Market Value ($) and Volume Forecast (2018-2023)
9.1.4 Anticoagulants Market Value ($) and Volume Forecast (2018-2023)
9.1.5 Others Market Value ($) and Volume Forecast (2018-2023)
9.2 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Application (2018-2023)
9.2.1 Hospital Market Value ($) and Volume Forecast (2018-2023)
9.2.2 Clinic Market Value ($) and Volume Forecast (2018-2023)
9.2.3 Home Market Value ($) and Volume Forecast (2018-2023)
10 NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS AND FORECAST BY REGION
10.1 North America Market Value ($) and Consumption Forecast (2018-2023)
10.2 Europe Market Value ($) and Consumption Forecast (2018-2023)
10.3 China Market Value ($) and Consumption Forecast (2018-2023)
10.4 Japan Market Value ($) and Consumption Forecast (2018-2023)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2018-2023)
10.6 India Market Value ($) and Consumption Forecast (2018-2023)
10.7 South America Market Value ($) and Consumption Forecast (2018-2023)
11 NEW PROJECT FEASIBILITY ANALYSIS
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 RESEARCH FINDING AND CONCLUSION
13 APPENDIX
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
1 NEUROLOGICAL DISORDER DRUGS INTRODUCTION AND MARKET OVERVIEW
1.1 Objectives of the Study
1.2 Definition of Neurological Disorder Drugs
1.3 Neurological Disorder Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Neurological Disorder Drugs Value ($) and Growth Rate from 2013-2023
1.4 Market Segmentation
1.4.1 Types of Neurological Disorder Drugs
1.4.2 Applications of Neurological Disorder Drugs
1.4.3 Research Regions
1.4.3.1 North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.2 Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.3 China Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.4 Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.5 Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.6 India Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.7 South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Neurological Disorder Drugs
1.5.1.2 Growing Market of Neurological Disorder Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 INDUSTRY CHAIN ANALYSIS
2.1 Upstream Raw Material Suppliers of Neurological Disorder Drugs Analysis
2.2 Major Players of Neurological Disorder Drugs
2.2.1 Major Players Manufacturing Base and Market Share of Neurological Disorder Drugs in 2017
2.2.2 Major Players Product Types in 2017
2.3 Neurological Disorder Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Neurological Disorder Drugs
2.3.3 Raw Material Cost of Neurological Disorder Drugs
2.3.4 Labor Cost of Neurological Disorder Drugs
2.4 Market Channel Analysis of Neurological Disorder Drugs
2.5 Major Downstream Buyers of Neurological Disorder Drugs Analysis
3 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET, BY TYPE
3.1 Global Neurological Disorder Drugs Value ($) and Market Share by Type (2013-2018)
3.2 Global Neurological Disorder Drugs Production and Market Share by Type (2013-2018)
3.3 Global Neurological Disorder Drugs Value ($) and Growth Rate by Type (2013-2018)
3.4 Global Neurological Disorder Drugs Price Analysis by Type (2013-2018)
4 NEUROLOGICAL DISORDER DRUGS MARKET, BY APPLICATION
4.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2013-2018)
4.2 Downstream Buyers by Application
4.3 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2013-2018)
5 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, VALUE ($) BY REGION (2013-2018)
5.1 Global Neurological Disorder Drugs Value ($) and Market Share by Region (2013-2018)
5.2 Global Neurological Disorder Drugs Production and Market Share by Region (2013-2018)
5.3 Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.4 North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.5 Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.6 China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.7 Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.8 Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.9 India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.10 South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
6 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2013-2018)
6.1 Global Neurological Disorder Drugs Consumption by Regions (2013-2018)
6.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.4 China Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.6 Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.7 India Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.8 South America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
7 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET STATUS AND SWOT ANALYSIS BY REGIONS
7.1 North America Neurological Disorder Drugs Market Status and SWOT Analysis
7.2 Europe Neurological Disorder Drugs Market Status and SWOT Analysis
7.3 China Neurological Disorder Drugs Market Status and SWOT Analysis
7.4 Japan Neurological Disorder Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Neurological Disorder Drugs Market Status and SWOT Analysis
7.6 India Neurological Disorder Drugs Market Status and SWOT Analysis
7.7 South America Neurological Disorder Drugs Market Status and SWOT Analysis
8 COMPETITIVE LANDSCAPE
8.1 Competitive Profile
8.2 Bayer AG
8.2.1 Company Profiles
8.2.2 Neurological Disorder Drugs Product Introduction
8.2.3 Bayer AG Production, Value ($), Price, Gross Margin 2013-2018E
8.2.4 Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.3 Merck & Co.
8.3.1 Company Profiles
8.3.2 Neurological Disorder Drugs Product Introduction
8.3.3 Merck & Co. Production, Value ($), Price, Gross Margin 2013-2018E
8.3.4 Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Profiles
8.4.2 Neurological Disorder Drugs Product Introduction
8.4.3 F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
8.4.4 F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.5 GlaxoSmithKline plc
8.5.1 Company Profiles
8.5.2 Neurological Disorder Drugs Product Introduction
8.5.3 GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2013-2018E
8.5.4 GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.6 Boehringer Ingelheim GmbH
8.6.1 Company Profiles
8.6.2 Neurological Disorder Drugs Product Introduction
8.6.3 Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2013-2018E
8.6.4 Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.7 AstraZeneca
8.7.1 Company Profiles
8.7.2 Neurological Disorder Drugs Product Introduction
8.7.3 AstraZeneca Production, Value ($), Price, Gross Margin 2013-2018E
8.7.4 AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.8 Teva Pharmaceutical Industries Ltd.
8.8.1 Company Profiles
8.8.2 Neurological Disorder Drugs Product Introduction
8.8.3 Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
8.8.4 Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.9 Novartis AG
8.9.1 Company Profiles
8.9.2 Neurological Disorder Drugs Product Introduction
8.9.3 Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E
8.9.4 Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
9 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION
9.1 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Type (2018-2023)
9.1.1 Antipsychotic Market Value ($) and Volume Forecast (2018-2023)
9.1.2 Hypnotic & Sedative Market Value ($) and Volume Forecast (2018-2023)
9.1.3 Analgesics Market Value ($) and Volume Forecast (2018-2023)
9.1.4 Anticoagulants Market Value ($) and Volume Forecast (2018-2023)
9.1.5 Others Market Value ($) and Volume Forecast (2018-2023)
9.2 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Application (2018-2023)
9.2.1 Hospital Market Value ($) and Volume Forecast (2018-2023)
9.2.2 Clinic Market Value ($) and Volume Forecast (2018-2023)
9.2.3 Home Market Value ($) and Volume Forecast (2018-2023)
10 NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS AND FORECAST BY REGION
10.1 North America Market Value ($) and Consumption Forecast (2018-2023)
10.2 Europe Market Value ($) and Consumption Forecast (2018-2023)
10.3 China Market Value ($) and Consumption Forecast (2018-2023)
10.4 Japan Market Value ($) and Consumption Forecast (2018-2023)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2018-2023)
10.6 India Market Value ($) and Consumption Forecast (2018-2023)
10.7 South America Market Value ($) and Consumption Forecast (2018-2023)
11 NEW PROJECT FEASIBILITY ANALYSIS
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 RESEARCH FINDING AND CONCLUSION
13 APPENDIX
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
LIST OF TABLES AND FIGURES
Figure Product Picture of Neurological Disorder Drugs
Table Product Specification of Neurological Disorder Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate from 2013-2023
Table Different Types of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Value ($) Segment by Type from 2013-2018
Figure Antipsychotic Picture
Figure Hypnotic & Sedative Picture
Figure Analgesics Picture
Figure Anticoagulants Picture
Figure Others Picture
Table Different Applications of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Value ($) Segment by Applications from 2013-2018
Figure Hospital Picture
Figure Clinic Picture
Figure Home Picture
Table Research Regions of Neurological Disorder Drugs
Figure North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Figure Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table China Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table India Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table Emerging Countries of Neurological Disorder Drugs
Table Growing Market of Neurological Disorder Drugs
Figure Industry Chain Analysis of Neurological Disorder Drugs
Table Upstream Raw Material Suppliers of Neurological Disorder Drugs with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Neurological Disorder Drugs in 2017
Table Major Players Neurological Disorder Drugs Product Types in 2017
Figure Production Process of Neurological Disorder Drugs
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Channel Status of Neurological Disorder Drugs
Table Major Distributors of Neurological Disorder Drugs with Contact Information
Table Major Downstream Buyers of Neurological Disorder Drugs with Contact Information
Table Global Neurological Disorder Drugs Value ($) by Type (2013-2018)
Table Global Neurological Disorder Drugs Value ($) Share by Type (2013-2018)
Figure Global Neurological Disorder Drugs Value ($) Share by Type (2013-2018)
Table Global Neurological Disorder Drugs Production by Type (2013-2018)
Table Global Neurological Disorder Drugs Production Share by Type (2013-2018)
Figure Global Neurological Disorder Drugs Production Share by Type (2013-2018)
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Antipsychotic
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Hypnotic & Sedative
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Analgesics
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Anticoagulants
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Others
Table Global Neurological Disorder Drugs Price by Type (2013-2018)
Table Global Neurological Disorder Drugs Consumption by Application (2013-2018)
Table Global Neurological Disorder Drugs Consumption Market Share by Application (2013-2018)
Figure Global Neurological Disorder Drugs Consumption Market Share by Application (2013-2018)
Table Downstream Buyers Introduction by Application
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2013-2018)
Table Global Neurological Disorder Drugs Value ($) by Region (2013-2018)
Table Global Neurological Disorder Drugs Value ($) Market Share by Region (2013-2018)
Figure Global Neurological Disorder Drugs Value ($) Market Share by Region (2013-2018)
Table Global Neurological Disorder Drugs Production by Region (2013-2018)
Table Global Neurological Disorder Drugs Production Market Share by Region (2013-2018)
Figure Global Neurological Disorder Drugs Production Market Share by Region (2013-2018)
Table Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Global Neurological Disorder Drugs Consumption by Regions (2013-2018)
Figure Global Neurological Disorder Drugs Consumption Share by Regions (2013-2018)
Table North America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table China Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table India Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table South America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Figure North America Neurological Disorder Drugs Production and Growth Rate Analysis
Figure North America Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure North America Neurological Disorder Drugs SWOT Analysis
Figure Europe Neurological Disorder Drugs Production and Growth Rate Analysis
Figure Europe Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure Europe Neurological Disorder Drugs SWOT Analysis
Figure China Neurological Disorder Drugs Production and Growth Rate Analysis
Figure China Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure China Neurological Disorder Drugs SWOT Analysis
Figure Japan Neurological Disorder Drugs Production and Growth Rate Analysis
Figure Japan Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure Japan Neurological Disorder Drugs SWOT Analysis
Figure Middle East & Africa Neurological Disorder Drugs Production and Growth Rate Analysis
Figure Middle East & Africa Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure Middle East & Africa Neurological Disorder Drugs SWOT Analysis
Figure India Neurological Disorder Drugs Production and Growth Rate Analysis
Figure India Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure India Neurological Disorder Drugs SWOT Analysis
Figure South America Neurological Disorder Drugs Production and Growth Rate Analysis
Figure South America Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure South America Neurological Disorder Drugs SWOT Analysis
Figure Top 3 Market Share of Neurological Disorder Drugs Companies
Figure Top 6 Market Share of Neurological Disorder Drugs Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Bayer AG Production, Value ($), Price, Gross Margin 2013-2018E
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2013-2018E
Figure Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Merck & Co. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2013-2018E
Figure Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Value ($) Market Share 2013-2018E
Figure F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2013-2018E
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2013-2018E
Figure GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2013-2018E
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2013-2018E
Figure Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table AstraZeneca Production, Value ($), Price, Gross Margin 2013-2018E
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2013-2018E
Figure AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2013-2018E
Figure Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2013-2018E
Figure Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Global Neurological Disorder Drugs Market Value ($) Forecast, by Type
Table Global Neurological Disorder Drugs Market Volume Forecast, by Type
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Antipsychotic (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Antipsychotic (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Hypnotic & Sedative (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Hypnotic & Sedative (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Analgesics (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Analgesics (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Anticoagulants (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Anticoagulants (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Others (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Others (2018-2023)
Table Global Market Value ($) Forecast by Application (2018-2023)
Table Global Market Volume Forecast by Application (2018-2023)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2013-2018)
Figure Market Value ($) and Growth Rate Forecast of Home (2018-2023)
Figure Market Volume and Growth Rate Forecast of Home (2018-2023)
Figure North America Market Value ($) and Growth Rate Forecast (2018-2023)
Table North America Consumption and Growth Rate Forecast (2018-2023)
Figure Europe Market Value ($) and Growth Rate Forecast (2018-2023)
Table Europe Consumption and Growth Rate Forecast (2018-2023)
Figure China Market Value ($) and Growth Rate Forecast (2018-2023)
Table China Consumption and Growth Rate Forecast (2018-2023)
Figure Japan Market Value ($) and Growth Rate Forecast (2018-2023)
Table Japan Consumption and Growth Rate Forecast (2018-2023)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2018-2023)
Table Middle East & Africa Consumption and Growth Rate Forecast (2018-2023)
Figure India Market Value ($) and Growth Rate Forecast (2018-2023)
Table India Consumption and Growth Rate Forecast (2018-2023)
Figure South America Market Value ($) and Growth Rate Forecast (2018-2023)
Table South America Consumption and Growth Rate Forecast (2018-2023)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Figure Product Picture of Neurological Disorder Drugs
Table Product Specification of Neurological Disorder Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate from 2013-2023
Table Different Types of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Value ($) Segment by Type from 2013-2018
Figure Antipsychotic Picture
Figure Hypnotic & Sedative Picture
Figure Analgesics Picture
Figure Anticoagulants Picture
Figure Others Picture
Table Different Applications of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Value ($) Segment by Applications from 2013-2018
Figure Hospital Picture
Figure Clinic Picture
Figure Home Picture
Table Research Regions of Neurological Disorder Drugs
Figure North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Figure Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table China Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table India Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
Table Emerging Countries of Neurological Disorder Drugs
Table Growing Market of Neurological Disorder Drugs
Figure Industry Chain Analysis of Neurological Disorder Drugs
Table Upstream Raw Material Suppliers of Neurological Disorder Drugs with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Neurological Disorder Drugs in 2017
Table Major Players Neurological Disorder Drugs Product Types in 2017
Figure Production Process of Neurological Disorder Drugs
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Channel Status of Neurological Disorder Drugs
Table Major Distributors of Neurological Disorder Drugs with Contact Information
Table Major Downstream Buyers of Neurological Disorder Drugs with Contact Information
Table Global Neurological Disorder Drugs Value ($) by Type (2013-2018)
Table Global Neurological Disorder Drugs Value ($) Share by Type (2013-2018)
Figure Global Neurological Disorder Drugs Value ($) Share by Type (2013-2018)
Table Global Neurological Disorder Drugs Production by Type (2013-2018)
Table Global Neurological Disorder Drugs Production Share by Type (2013-2018)
Figure Global Neurological Disorder Drugs Production Share by Type (2013-2018)
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Antipsychotic
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Hypnotic & Sedative
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Analgesics
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Anticoagulants
Figure Global Neurological Disorder Drugs Value ($) and Growth Rate of Others
Table Global Neurological Disorder Drugs Price by Type (2013-2018)
Table Global Neurological Disorder Drugs Consumption by Application (2013-2018)
Table Global Neurological Disorder Drugs Consumption Market Share by Application (2013-2018)
Figure Global Neurological Disorder Drugs Consumption Market Share by Application (2013-2018)
Table Downstream Buyers Introduction by Application
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2013-2018)
Table Global Neurological Disorder Drugs Value ($) by Region (2013-2018)
Table Global Neurological Disorder Drugs Value ($) Market Share by Region (2013-2018)
Figure Global Neurological Disorder Drugs Value ($) Market Share by Region (2013-2018)
Table Global Neurological Disorder Drugs Production by Region (2013-2018)
Table Global Neurological Disorder Drugs Production Market Share by Region (2013-2018)
Figure Global Neurological Disorder Drugs Production Market Share by Region (2013-2018)
Table Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
Table Global Neurological Disorder Drugs Consumption by Regions (2013-2018)
Figure Global Neurological Disorder Drugs Consumption Share by Regions (2013-2018)
Table North America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table China Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table India Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Table South America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
Figure North America Neurological Disorder Drugs Production and Growth Rate Analysis
Figure North America Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure North America Neurological Disorder Drugs SWOT Analysis
Figure Europe Neurological Disorder Drugs Production and Growth Rate Analysis
Figure Europe Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure Europe Neurological Disorder Drugs SWOT Analysis
Figure China Neurological Disorder Drugs Production and Growth Rate Analysis
Figure China Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure China Neurological Disorder Drugs SWOT Analysis
Figure Japan Neurological Disorder Drugs Production and Growth Rate Analysis
Figure Japan Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure Japan Neurological Disorder Drugs SWOT Analysis
Figure Middle East & Africa Neurological Disorder Drugs Production and Growth Rate Analysis
Figure Middle East & Africa Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure Middle East & Africa Neurological Disorder Drugs SWOT Analysis
Figure India Neurological Disorder Drugs Production and Growth Rate Analysis
Figure India Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure India Neurological Disorder Drugs SWOT Analysis
Figure South America Neurological Disorder Drugs Production and Growth Rate Analysis
Figure South America Neurological Disorder Drugs Consumption and Growth Rate Analysis
Figure South America Neurological Disorder Drugs SWOT Analysis
Figure Top 3 Market Share of Neurological Disorder Drugs Companies
Figure Top 6 Market Share of Neurological Disorder Drugs Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Bayer AG Production, Value ($), Price, Gross Margin 2013-2018E
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2013-2018E
Figure Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Merck & Co. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2013-2018E
Figure Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Value ($) Market Share 2013-2018E
Figure F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2013-2018E
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2013-2018E
Figure GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2013-2018E
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2013-2018E
Figure Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table AstraZeneca Production, Value ($), Price, Gross Margin 2013-2018E
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2013-2018E
Figure AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2013-2018E
Figure Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Company Profiles
Table Product Introduction
Table Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2013-2018E
Figure Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
Table Global Neurological Disorder Drugs Market Value ($) Forecast, by Type
Table Global Neurological Disorder Drugs Market Volume Forecast, by Type
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Antipsychotic (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Antipsychotic (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Hypnotic & Sedative (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Hypnotic & Sedative (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Analgesics (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Analgesics (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Anticoagulants (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Anticoagulants (2018-2023)
Figure Global Neurological Disorder Drugs Market Value ($) and Growth Rate Forecast of Others (2018-2023)
Figure Global Neurological Disorder Drugs Market Volume and Growth Rate Forecast of Others (2018-2023)
Table Global Market Value ($) Forecast by Application (2018-2023)
Table Global Market Volume Forecast by Application (2018-2023)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2013-2018)
Figure Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2013-2018)
Figure Market Value ($) and Growth Rate Forecast of Home (2018-2023)
Figure Market Volume and Growth Rate Forecast of Home (2018-2023)
Figure North America Market Value ($) and Growth Rate Forecast (2018-2023)
Table North America Consumption and Growth Rate Forecast (2018-2023)
Figure Europe Market Value ($) and Growth Rate Forecast (2018-2023)
Table Europe Consumption and Growth Rate Forecast (2018-2023)
Figure China Market Value ($) and Growth Rate Forecast (2018-2023)
Table China Consumption and Growth Rate Forecast (2018-2023)
Figure Japan Market Value ($) and Growth Rate Forecast (2018-2023)
Table Japan Consumption and Growth Rate Forecast (2018-2023)
Figure Middle East & Africa Market Value ($) and Growth Rate Forecast (2018-2023)
Table Middle East & Africa Consumption and Growth Rate Forecast (2018-2023)
Figure India Market Value ($) and Growth Rate Forecast (2018-2023)
Table India Consumption and Growth Rate Forecast (2018-2023)
Figure South America Market Value ($) and Growth Rate Forecast (2018-2023)
Table South America Consumption and Growth Rate Forecast (2018-2023)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
